A survey of Alzheimer’s disease prevalence in Norway confirms earlier estimates and might show how education level relates to ...
The FDA expanded its approval of Addyi to treat low libido in postmenopausal women up to age 65. The approval will open up ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results